Table II.

Body weight, tumor weight and tumor volume in ovarian cancer xenografts.

A, A2780 xenografts
Treatment	n	Weight (g)		Tumor volume	Tumor weight	TIR
		Day 0	Day 31
Control	5/8	20.88±0.18	22.47±0.89	2465.0±459.1	2.12±0.34
Dasatinib	6/12	20.93±0.72	22.37±0.89	1400.2±231.3	1.67±0.30	43.197
Paclitaxel	6/11	21.17±0.45	23.08±0.72	1016.9±176.3	1.34±0.20	58.764
Combined	6/11	21.25±0.41	21.7±1.1	574.3±126.1	0.93±0.19	76.702

B, HO8910 xenografts
Treatment	n	Weight (g)		Tumor volume	Tumor weight	TIR
		Day 0	Day 31
Control	6/11	18.30±0.60	22.32±0.40	1695.2±162.5	2.65±0.28
Dasatinib	6/10	19.10±0.66	20.88±0.58	1119±168.6	1.55±0.30	33.99
Paclitaxel	6/12	19.45±0.66	20.57±0.88	923.2±139.9	1.54±0.22	45.54
Combined	6/10	17.28±0.51	20.35±0.57	698.3±145.7	1.65±0.42	58.51

Tumor volume (mm³); tumor weight (g); TIR (%). Data are presented as the mean ± standard deviation. TIR, tumor growth inhibitory rates.